{"filing":{"accession_number":"0001575872-26-000709","cik":"0001543637","ticker":"NUMD","company_name":"Nu-Med Plus, Inc.","form":"8-K","filing_date":"2026-10-20","report_date":"2026-10-19","primary_document":"numd_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1543637/000157587226000709/numd_8k.htm"},"events":[{"id":36311,"run_id":33476,"accession_number":"0001575872-26-000709","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"Nu-Med Plus entered into Subscription Agreements with accredited investors to sell 171,232 shares of Series A Preferred Stock for $450,000, and issued 50,000 shares of Series A Preferred Stock to a consultant, pursuant to Section 4(a)(2) and Regulation D exemptions. Upon full conversion, these securities would result in the issuance of approximately 4.4 million shares of common stock, materially diluting existing shareholders.","company_name":"Nu-Med Plus, Inc.","ticker":"NUMD","filing_date":"2026-10-20","form":"8-K","submitted_at":null,"items":[{"id":40686,"accession_number":"0001575872-26-000709","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Nu-Med Plus entered into Subscription Agreements with accredited investors to sell 171,232 shares of Series A Preferred Stock for $450,000. This is a private placement of equity securities convertible into common stock, with piggy-back registration rights granted to investors. The transaction represents a dilutive issuance of equity capital, typical of small- to mid-cap companies raising cash through unregistered securities sales.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-20T12:57:47.377472+00:00","company_name":"","ticker":null,"filing_date":""},{"id":40688,"accession_number":"0001575872-26-000709","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 3.02 disclosure of unregistered sales of equity securities is the canonical indicator of a dilutive issuance event. This typically signals a private placement, PIPE, or other unregistered equity offering—a material capital-raising activity that dilutes existing shareholders and is particularly significant at smaller issuers like Nu-Med Plus.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-20T12:57:47.377472+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":40686,"accession_number":"0001575872-26-000709","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Nu-Med Plus entered into Subscription Agreements with accredited investors to sell 171,232 shares of Series A Preferred Stock for $450,000. This is a private placement of equity securities convertible into common stock, with piggy-back registration rights granted to investors. The transaction represents a dilutive issuance of equity capital, typical of small- to mid-cap companies raising cash through unregistered securities sales.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-20T12:57:47.377472+00:00","company_name":"Nu-Med Plus, Inc.","ticker":"NUMD","filing_date":"2026-10-20"},{"id":40688,"accession_number":"0001575872-26-000709","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 3.02 disclosure of unregistered sales of equity securities is the canonical indicator of a dilutive issuance event. This typically signals a private placement, PIPE, or other unregistered equity offering—a material capital-raising activity that dilutes existing shareholders and is particularly significant at smaller issuers like Nu-Med Plus.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-20T12:57:47.377472+00:00","company_name":"Nu-Med Plus, Inc.","ticker":"NUMD","filing_date":"2026-10-20"}]}